Skip to main navigation Skip to search Skip to main content

Legumain in cardiovascular disease: Culprit or ally?

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)66-67
Number of pages2
JournalAtherosclerosis
Volume296
DOIs
Publication statusPublished - Mar 2020

Keywords

  • Biomarkers
  • Legumain
  • Macrophages
  • Cysteine Endopeptidases
  • Cardiovascular Diseases
  • Anti-Inflammatory Agents
  • Humans

Cite this